Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

73.91
+1.211.66%
Volume:572.47K
Turnover:41.95M
Market Cap:14.24B
PE:-17.66
High:74.27
Open:74.02
Low:72.42
Close:72.70
52wk High:75.10
52wk Low:25.34
Shares:192.71M
Float Shares:151.20M
Volume Ratio:0.62
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-7.37
PE(LYR):-25.67

Loading ...

BridgeBio Pharma Publishes Study on Acoramidis for ATTR-CM

Reuters
·
Nov 10

BridgeBio presents data from ATTRibute-CM study on acoramidis

TIPRANKS
·
Nov 10

Biotech stocks are coming back. Here's what's driving the sector higher.

Dow Jones
·
Nov 09

BridgeBio Pharma Inc. publishes ATTRibute-CM trial results on transthyretin amyloid cardiomyopathy

Reuters
·
Nov 08

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

GlobeNewswire
·
Nov 08

BridgeBio Pharma Director Ronald J. Daniels Reports Disposal of Common Shares

Reuters
·
Nov 08

BridgeBio Pharma Inc : Mizuho Raises Target Price to $91 From $64

THOMSON REUTERS
·
Nov 04

Biotech Stocks Are Coming Back. Here's What's Driving The Sector Higher.

Dow Jones
·
Nov 04

BridgeBio Oncology Therapeutics to Present at Jefferies Global Healthcare Conference

Reuters
·
Nov 04

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

Dow Jones
·
Nov 03

BridgeBio Reports Acoramidis Reduces Mortality and Hospitalizations in ATTR-CM Study

Reuters
·
Nov 03

BridgeBio Pharma Price Target Maintained With a $90.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 03

BridgeBio Pharma (BBIO): Negative Equity Underscores Balance Sheet Risk Despite Forecasted Profit Growth

Simply Wall St.
·
Oct 31

BridgeBio Oncology Therapeutics Unveils Promising BBO-10203 Breast Cancer Data at SABCS

Reuters
·
Oct 31

BridgeBio price target raised to $80 from $66 at Truist

TIPRANKS
·
Oct 31

BridgeBio Pharma Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Oct 30

BridgeBio Pharma Price Target Raised to $80.00/Share From $66.00 by Truist Securities

Dow Jones
·
Oct 30

U.S. RESEARCH ROUNDUP- Alphabet, Boeing, KLA

Reuters
·
Oct 30

BridgeBio Pharma Inc : TD Cowen Raises Target Price to $95 From $60

THOMSON REUTERS
·
Oct 30

TD Cowen Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
Oct 30